Navigation Links
International Symposium on Malignant Mesothelioma 2008
Date:5/28/2008

Targeting a Cure

WASHINGTON, May 28 /PRNewswire/ -- Leading international experts on the asbestos-related cancer, mesothelioma, will join meso patients, caregivers, loved ones and advocates to share the latest in treatment, research and clinical trials at the Mesothelioma Applied Research Foundation's International Symposium on Malignant Mesothelioma, 2008, Thursday, June 26 - Saturday, June 28 at the Hyatt Regency on Capitol Hill, in Washington, D.C.

The Symposium, organized annually by the Meso Foundation, will highlight the latest advances in research and treatment for patients and caregivers, offer psychosocial support to them as well as those who have lost someone to the disease, and provide significant advocacy and volunteer opportunities for all who are intent on eradicating the vicious and terminal effects of this tragic cancer.

Day 1: Advocacy, Thursday, June 26 is a rallying cry to the House of Representatives to move quickly on legislation banning asbestos and providing research funding for meso and asbestos related diseases. This legislation must be conferenced with the companion bill in the Senate and signed into law by the President before year-end. The second advocacy objective is to request that the Senate's Defense Appropriations Subcommittee maintain, for a second year, mesothelioma's eligibility to compete for medical research funding from the Department of Defense.

The Symposium's Co-Chairs, Dr. Nicholas J. Vogelzang, Chairman of the Meso Foundation's Board of Directors and the Director of Nevada Cancer Institute, and Dr. Raffit Hassan, Chairman of the Meso Foundation's Science Advisory Board and an Investigator at the National Cancer Institute, have put together an impressive and prestigious group of panelists for Day 2: Science, Friday, June 27.

A Gala Dinner will be held Friday evening, June 27, with three awards presented to individuals in recognition of their special contrib
'/>"/>

SOURCE Mesothelioma Applied Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/-- CryoLife,Inc. (NYSE:...iovasculartissueprocessingcompany,announcedtodayth...ray21stAnnualHealthCareConferenceatTheNewYorkPalac...sidentandchiefexecutiveofficerofCryoLife,Inc.,will...tdevelopmentsandhostaquestionandanswersessionat4:3...
(Date:11/23/2009)...,Tenn.,Nov.23/PRNewswire-FirstCall/-- CumberlandPh...newtop-lineresultsfromastudyevaluatingthesafetyand...feverinhospitalizedburnpatients. ,, Statistical...cingfeverinburnpatientsoverthefirst24hoursoftreatm...orthirddegreeburnscoveringmorethan10percenttotalbo...
(Date:11/23/2009)...IRE,Ill.,Nov.23/PRNewswire/--Sarnova,Inc.,thenatio...intheemergencymedicalservices(EMS)andrespiratoryma...estoitsseniormanagementteam.Thenewexecutivesinclud...executivevicepresidentandgeneralcounsel;SteveLacke...le,executivevicepresidentofcorporatedevelopment. ,...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Sarnova Expands Senior Management Team 2Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 1Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 2Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 3Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 4Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group 5914 1Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group 5914 2Texas Cardiac Arrhythmia Institute at St Davids Medical Center First in the United States to Utilize Newly FDA Cleared CARTO 28R 29 3 Navigation Syst 5912 1Texas Cardiac Arrhythmia Institute at St Davids Medical Center First in the United States to Utilize Newly FDA Cleared CARTO 28R 29 3 Navigation Syst 5912 2
...shy; May 14, 2007-Acceleron Pharma, Inc., a,biopha...e treatment,of musculoskeletal, metabolic and canc...preclinical study with ACE-031 that,demonstrated t...,and strength in normal mice and in murine models ...egulators of muscle to,increase muscle mass and st...
...BUSINESS WIRE)--May 15, 2007 - Reata,Pharmaceutica...icle,in the May 2007 issue of the journal Cancer R...2 development candidate for cancer,was highly eff...,and that the drug inhibits signaling activity of ...s., The article, "The Novel Triterpenoid C-28 Meth...
Other Medicine Technology:Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies 2Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies 3RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds,Significant Promise for Treating Breast Cancer 2RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds,Significant Promise for Treating Breast Cancer 3
(Date:11/23/2009)...an three-quarters getting chemo deal with insomnia...hDay News) -- Insomnia and sleep disorders affect ...oing chemotherapy, a rate nearly three times highe... finds. , The problem is more common in younger...s, said University of Rochester Medical Center res...
(Date:11/23/2009)... CENTERCITY,Minn.,Nov.23/PRNewswire/--Hazelden,the...center,todayannouncedtheleadershipteamforitsnewrec...tyinNaplesisscheduledtoopeninlateMarch2010,andwill...s,includingafullarrayoffamilyandoutpatientservices...rectorofHazelden,sfacilityinNaples,withBrendaIliff...
(Date:11/23/2009)... WASHINGTON,Nov.23/PRNewswire-USNewswire/-- The A...,slargestindividualmembershipassociationofstateleg...ativeTimScott forpre-filinga constitutionalamendme...lthcarechoices.SouthCarolinanowbecomesthe24thstate...islationmodeledafterALEC,s FreedomofChoiceinHealth...
(Date:11/23/2009)...EN, N.J. The Center for Science Writings at Steve...tion of God," a talk by Robert Wright, journalist ... 2, 2009, 4:00-5:30 p.m. at the Babbio Center for ... and open to the public and the media., In his n...urnalist Robert Wright, renowned for his popular w...
(Date:11/23/2009)...rsity of Alberta graduate student Jennifer Heys wa...ore education in Ugandan communities about contrac...iduals and their desire to bear more children, was...red last week at the International Conference on F...tudied at the School of Public Health, spent six m...
Breaking Medicine News(10 mins):Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:South Carolina Now 24th State to Defend Health Care Choice 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2
...inical,Meeting and Exhibition -- Omnicell, Inc., (...tions to acute healthcare facilities, and Brigham ... of Harvard Medical School located in,the heart ...ion management system. With the integration of the...
...od costs, many,families are economizing on groceri...trition. At about 25 cents per 8-ounce glass, on a...y than almost any other beverage option in the,sup...m,their grocery lists, the National got milk? Camp...
... announced today that Dr. Jonathan White will join...Vice President of Haemonetics, effective December ... responsibility for leading development of the nex...As the global leader in blood management solutions...
...tories, Inc. (Nasdaq: IDXX ), today announced th...e Vice President, Instrument Research and Developm... Dr. Brown will oversee instrument development, ma... IDEXX,s strategy of technological innovation in d...
...Sciences, Inc. (Nasdaq: HGSI ) today announced t...he results of ACHIEVE 2/3, its Phase 3 trial of Al...titis C. , , (Logo: http://www.newscom.com/c...am Eastern Time. , , Investors may listen to ...
...irms what we already,know -- that U.S. consumers h...onths. More than one-third have made measurable c... according to Booz & Company (October 2008).,T...re,is a popular myth that fresh produce is too exp...
Other Medicine News:Health News:Brigham and Women's Hospital Selects SinglePointe(TM) Automated Patient-Specific Medication Management Solution from Omnicell 2Health News:Brigham and Women's Hospital Selects SinglePointe(TM) Automated Patient-Specific Medication Management Solution from Omnicell 3Health News:Milk is One Beverage Jackson Can't Afford to Keep Off the Grocery List 2Health News:Milk is One Beverage Jackson Can't Afford to Keep Off the Grocery List 3Health News:Dr. Jonathan White Joins Haemonetics as Head of Research and Development 2Health News:IDEXX Laboratories Names William Brown Corporate Vice President 2Health News:Human Genome Sciences to Sponsor Conference Call 2Health News:Healthy Eating and Good Nutrition Go Hand-in-Hand in Tight Economic Times 2
Pipetman F50
Ovation BioNatural Pipette, one-stroke, fixed volume, 50L
...on is precision, ergonomics, and value!, Comforta... contoured handle , Finer control while pipetting ...ely autoclavable for easy decontamination and ster...y-to-read precision micrometer for reproducible, a...
...pendorf Reference Series 2000 Pipette is a synonym...t and robust design, and superior operating comfor...perate the measuring stroke and blow-out as well a...te/tip" system ensures utmost accuracy and precisi...
Medicine Products: